USA - NASDAQ:INAB - US45674E2081 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to INAB. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-02-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-11 | Jones Trading | Upgrade | Hold -> Buy |
| 2024-11-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-12 | Jones Trading | Downgrade | Buy -> Hold |
| 2024-06-14 | Jones Trading | Maintains | Buy -> Buy |
| 2024-06-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-18 | Laidlaw & Co. | Initiate | Buy |
| 2024-03-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-13 | JonesTrading | Initiate | Buy |
| 2023-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-05 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-26 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-24 | Mizuho | Reiterate | Buy |
| 2023-04-17 | EF Hutton | Maintains | Buy |
| 2023-03-31 | EF Hutton | Reiterate | Buy |
| 2023-03-31 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-29 | EF Hutton | Initiate | Buy |
| 2022-11-11 | B. Riley Securities | Downgrade | Buy -> Neutral |
| 2022-08-30 | HC Wainwright & Co. | Initiate | Buy |
| 2022-01-24 | B. Riley Securities | Maintains | Buy |
| 2021-08-24 | Mizuho | Initiate | Buy |
| 2021-08-23 | B. Riley Securities | Initiate | Buy |
10 analysts have analysed INAB and the average price target is 50.24 USD. This implies a price increase of 2890.18% is expected in the next year compared to the current price of 1.68.
The consensus rating for IN8BIO INC (INAB) is 82 / 100 . This indicates that analysts generally have a positive outlook on the stock.